BioWorld MedTech

March 26, 2014

View Archived Issues

Latin America: Lack of accredited importers main barrier to entering the Colombian market

A rapidly improving economy, more stable politics and incremental improvements in the regulatory environment are all conspiring to make Colombia one of the most sought after med-tech markets in Latin America. Read More

Report From Israel, Part 2 of 2: Weizmann Institute creates national center for personalized medicine

Read More

DermTech completes validation of its pigmented lesion assay

Read More

Washington Roundup: FDA hints clinical trials may be appropriate for special controls

Read More

Financings Roundup: Nephros completes rights offering, nets $2.14 million

Read More

Agreements/contracts: PatientPoint, HealthTronics provide health management

Read More

New Ventures: MedLumics intitates BiopsyPen Project with EUR3.6 milion from EU

Read More

Briefly Noted

Read More

Product briefs

Read More

MDD's Oncology Extra

Read More